June 7, 2016, Polo de Innovación Garaia, Arrasate-Mondragón.  Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes happening in life science. He is a Distinguished Researcher with Autodesk in their Bio/Nano Research Group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Sin título

To take part in the conference, you can register in those links:

On June 9, he will focus on the educative side of the synthetic biology, in the Planetario of Pamplona, with a conference tittled “Understanding and designing how life is programed. Imagine the future with Andrew Hessel”.

And finnaly, On 10 June 2016, we will give a more scientific conference in CIC bioGUNE tittled “Synthetic Biology: Fundaments and Current Developments. Prof. Andrew Hessel”.

In both occasions, he will be accompanied by Cristina Vilanova, bringing her vision of synthetic biology as a student, researcher and entrepreneur. She is graduated in Biotechnology at the ‘Universidad Politécnica de Valencia (UPV)’ and she has completed the Masters in Molecular and Cellular Biology and Genetics at the ‘Universitat de València (UV)’. During her career as a researcher in training, she has worked with groups of molecular biology and genetics at the ‘Instituto de Biología Molecular y Celular de Plantas Primo Yúfera (UPV-CSIC)’ and with synthetic biology groups in the ‘Centro Nacional de Biotecnología (UAM-CSIC)’. In 2009 she participated in the iGEM competition (international Genetically Engineered Machine Competition) with a project awarded with the third prize in the world-class and for the best application and best experimental measure. Since then, she has worked as advisor of the iGEM teams representing the UP-UPV consortium. She is coauthor of several scientific articles, patents and oral presentations at conferences. She has participated in activities related to scientific dissemination, especially in collaboration with La Caixa Foundation and Mètode magazine. Currently, she is finishing her doctoral studies in Biotechnology and she has founded, with other researchers from the UV and CSIC, the Darwin Bioprospecting Excellence company, working in the isolation and optimization of bacterial strains.